FiscalNote sells assets, refinances debt to boost liquidity amid steep ARR decline

FiscalNote Holdings, Inc. (NASDAQ: DSAC) - Quick inside look

What's happening inside: the company is simplifying and refinancing. Management has sold non-core assets, cut costs and headcount, and completed a material debt refinance after the quarter (Aug 2025) to extend maturities and reduce near-term leverage. The business is refocusing on its core Policy/subscription offerings while using sale proceeds to pay down term debt.

Key facts & figures (from 2Q / YTD June 30, 2025)
* Total revenues: $23,264k (Q2 2025) vs $29,246k (Q2 2024); $50,775k (6M 2025) vs $61,358k (6M 2024) - down 20.5% quarter, 17.2% six months.
* Subscription revenue: $21,380k (Q2) / $46,612k (6M); down 21.3% Q/Q and 17.9% Y/Y for the six months.
* Operating loss: $(7,427)k (Q2); $(21,189)k (6M).
* Net loss: $(13,271)k (Q2); $(17,521)k (6M). Basic & diluted EPS: $(0.08) Q2, $(0.11) YTD.
* Adjusted Gross Profit Margin: 86% (Q2) - Adjusted Gross Profit $20,095k (Q2) / $44,154k (6M).
* Adjusted EBITDA: $2,801k (Q2) / $5,582k (6M). Adjusted EBITDA Margin: 12.0% (Q2) / 11.0% (6M).
* Gain on sale of businesses: $15,424k recorded in 6M 2025 (Dragonfly & Oxford Analytica sale closed Mar 31, 2025). Previous sale of Board.org generated $71,599k gain in 6M 2024.
* Cash, cash equivalents, restricted cash and short-term investments: $39.2M at June 30, 2025 (cash & equivalents $34,009k; short-term investments $4,508k).
* Total assets: $288,349k; Total liabilities: $190,535k (June 30, 2025). Accumulated deficit: $(824,420)k.
* Debt (gross): $119,856k at June 30, 2025; long-term debt, net of current maturities $116,748k. Prior Senior Term Loan outstanding $61,837k at 6/30/25 (retired Aug 12, 2025 per subsequent events).
* ARR: $85.9M at June 30, 2025 vs $107.5M at Dec 31, 2024 (material decline; dispositions and organic attrition cited).
* Working capital: negative $27.9M (excluding cash and short-term investments) at June 30, 2025.

Positive aspects of the income statement and financial actions
* High adjusted gross margins (86-87% range) indicate low direct cost base for subscription products.
* Adjusted EBITDA turned positive ($5.6M YTD) after cost rationalization and disposals - evidence costs are being right-sized.
* Material one-time gains from asset sales provided liquidity and enabled meaningful term-loan prepayments (e.g., $40.3M cash proceeds from Dragonfly/Oxford sale; used to retire ~$27.1M of term loans).
* Interest expense declined (6M interest $9,465k vs $12,682k prior year) as legacy term debt was reduced pre-refinance.
* Management completed a refinancing in August 2025 (post‑period) to push out maturities and secure $75M new Senior Term Loan plus debenture financing - increases runway if covenants are met.

Negative aspects of the income statement and risks
* Revenue decline: Total and subscription revenues fell significantly year-over-year (Q2 down ~21%; 6M down ~18%), driven by asset sales and weaker organic retention / federal customer cuts.
* ARR compression: ARR dropped materially to $85.9M from $107.5M (Dec 2024) - undermines recurring revenue outlook.
* Ongoing net losses and accumulated deficit ($824M) - the company is not yet profitable on GAAP basis.
* Operating loss widened YTD to $(21.2)M despite cost cuts; reliance on non-operating gains (asset sales) to offset cash burn is a concern.
* Leverage and debt instruments are complex: multiple convertible notes (GPO, Dragonfly, Era, Legacy), warrant liabilities and fair‑value volatility lead to income-statement swings (change in fair value charges/gains).
* Covenant sensitivity: the new 2025 Senior Term Loan (closed Aug 12, 2025) includes financial covenants (minimum cash, ARR, adjusted EBITDA and capex limits). Compliance depends on continued revenue recovery and cash management; breach could be severe.
* Customer concentration and government exposure: U.S. Federal Government ~18% of revenues (6M), and prior comment about single-customer/concentration risk in disclosures - revenue and collections sensitive to government spending cycles.

Operational/near-term items to watch
* Execution on revenue retention and ARR recovery (renewals, upsell, government contract stability).
* Covenant compliance under the 2025 Senior Term Loan and the impact of quarterly principal and cash interest obligations (Aug 2025 refinancing changed cash interest profile; company noted annualized cash interest ~ $9M post-transactions).
* Integration of ongoing product focus (Policy core) and whether reduced sales & R&D investment yields durable top-line stabilization without impairing growth.
* Further asset sales or equity issuance that could dilute shareholders - several convertible instruments and debenture conversions remain that can issue shares.
* Collections and accounts receivable (A/R decreased to $9,357k from $13,465k), and allowance for credit losses ($1,546k) - monitor receivables quality and cash conversion.

Bottom line (straightforward)
FiscalNote (NASDAQ: DSAC) has taken clear steps to stabilize its balance sheet: sold non-core assets for cash, reduced operating cost, and completed a post‑quarter refinancing to extend maturities. Those actions improved liquidity but top-line trends are weak (subscription revenue and ARR down materially). The company's adjusted margins and positive adjusted EBITDA show the underlying subscription business can be profitable after cost rationalization - but leverage, GAAP losses, and covenant risk mean the recovery depends on stabilizing ARR and consistent cash collections. Monitor quarterly ARR, covenant metrics under the new term loan, and any future convertible/debenture share issuance (dilution risk).